Education

Johnson & Johnson is taking a bold step in the fight against treatment-resistant depression by seeking FDA approval to use its ketamine-based drug, Spravato, as a standalone therapy. With promising trial results showing swift symptom relief, the stakes are high for individuals battling this challenging condition. What could this mean for the future of mental…

At 82 years old and facing health challenges, the Rev. Jesse L. Jackson Sr. made a notable appearance at the Democratic National Convention, receiving a heartfelt standing ovation. Discover his significant contributions to civil rights and the Democratic Party, as well as the legacy of his historic presidential campaigns. What does his journey reveal about…

Get ready for a captivating journey into the world of creativity with the premiere of “BEYOND THE CANVAS.” Season three invites viewers to explore the profound impact of art on our lives, featuring an array of talented individuals from surfers to trailblazing artists. Each episode promises to uncover new narratives that highlight how art shapes…

Phil Donahue, a pioneering force in daytime television, has passed away at 88 after a long illness. His groundbreaking show transformed the talk show landscape, taking on serious issues with a unique blend of warmth and assertiveness. Discover the legacy of a man who dared to challenge societal norms and engage deeply with his audience.

Johnson & Johnson is making a bold move to expand the use of its innovative ketamine-based drug, Spravato, seeking FDA approval for it to be a standalone treatment for those battling treatment-resistant depression. With promising results showing relief within 24 hours, the implications for millions of sufferers are significant. Dive into the details of this…

Selom Ametepe, a dedicated doctoral candidate in Cell and Molecular Biology, has been honored with the prestigious DeLill Nasser Travel Award. This recognition not only celebrates her remarkable contributions to genetics but also provides crucial support for her research and professional development. Delve into her inspiring journey and learn how she plans to leverage this…

Selom Ametepe, an international doctoral candidate, has garnered prestigious recognition with the DeLill Nasser Travel Award from the Genetics Society of America. This award will propel her research in cell and molecular biology, enabling her to attend significant conferences and enhance her skills. Dive into Ametepe’s inspiring journey from Togo to groundbreaking genetic research and…

Selom Ametepe, a dedicated doctoral candidate, has been awarded the prestigious DeLill Nasser Travel Award for her outstanding contributions to genetics research. This recognition opens doors for her to attend pivotal conferences and enhance her skills. Discover how her journey from Togo to groundbreaking research in the nervous system of fruit flies is set to…

Selom Ametepe, an inspiring doctoral candidate, has been awarded the DeLill Nasser Travel Award for her groundbreaking work in genetics. This prestigious recognition will support her attendance at major conferences worldwide and advance her research on the nervous system. Discover how her journey from Togo to a leading U.S. university is shaping the future of…

Johnson & Johnson is taking a significant step in the fight against treatment-resistant depression by seeking FDA approval for Spravato as a standalone therapy. This groundbreaking ketamine-based nasal spray could offer hope to millions who struggle with persistent depression. What does this mean for the future of mental health treatment? Discover the details and implications…

Johnson & Johnson is making a bold move in the fight against treatment-resistant depression by seeking FDA approval for Spravato as a standalone therapy. This ketamine-based medication could offer hope to millions who struggle with severe depression, promising symptom relief in just 24 hours. Discover the potential impact of this groundbreaking development in mental health…

Johnson & Johnson is making strides in the fight against treatment-resistant depression by seeking FDA approval to use its ketamine-based medication, Spravato, as a standalone therapy. With a significant portion of the 280 million individuals living with major depressive disorder not finding relief from conventional treatments, this could be a game-changer. Discover how this innovative…

Johnson & Johnson is taking a bold step to redefine treatment-resistant depression by seeking FDA approval to use its ketamine-based drug, Spravato, as a standalone therapy. With promising results showing rapid relief from symptoms, could this be a game-changer for the millions struggling with ineffective treatments? Discover the potential implications of this new application and…

Johnson & Johnson is taking a significant step in the fight against treatment-resistant depression. They’ve submitted a request to the FDA to expand the use of their ketamine-derived medication, Spravato, allowing it to be used independently for patients who struggle with conventional treatments. What does this mean for the millions affected by depression? The latest…

Columbia University is set for a leadership change as President Minouche Shafik announces her resignation amid recent campus unrest. Shafik reflects on her tenure and the challenges faced, while the university prepares for a new chapter. What does this mean for the future of Columbia? Find out more in our full article.

In a surprising turn of events, Columbia University’s President Minouche Shafik has announced her resignation amid significant campus protests and scrutiny over the university’s recent actions. As the first female president of the institution, her tenure has been marked by both progress and challenges. What does this mean for the future of Columbia? Dive into…

Johnson & Johnson is making strides in the fight against depression by proposing a standalone treatment for patients with treatment-resistant depression using their ketamine-based medication, Spravato. With promising clinical trial results suggesting rapid symptom relief, this development could redefine approaches to managing this challenging condition. Could this be a game-changer for the millions struggling with…

Mpox has been declared a global public health emergency once again, amid a worrying rise in cases across Africa. With over 17,000 suspected infections this year, the spread of a new variant raises serious concerns. What does this mean for global health, and how can communities prepare? Dive into the details of this escalating situation.

Ilhan Omar celebrates a decisive victory in the Democratic primary, outpacing her challenger by 13 points. With a robust campaign and a strong community connection, she’s positioned for success in the upcoming general election. What does this mean for the future of her district and progressive politics? Dive into the details of this pivotal moment.

Humanitarian photographer Lisa Kristine has been honored with the 2024 Artist Award by the EPIC Impact Society. Renowned for her powerful imagery that advocates for social justice and global unity, Kristine’s journey spans over 150 countries, igniting conversations on crucial issues like modern slavery and indigenous rights. Discover the impact of her work and the…

Exciting changes are on the horizon for the John D. Odegard School of Aerospace Sciences! Discover how the upcoming classroom renovations are set to create modern, inviting spaces that enhance learning and promote sustainability. What innovative features will be introduced in the newly upgraded facilities? Find out more about this transformative initiative as the school…